Similarities and differences in the mechanism of action of antidepressants

被引：0
|
作者：
Kirli, Selcuk [1 ]
机构：
[1] Uludag Univ, Tip Fak, Psikiyatri Anabilim Dali, Bursa, Turkey
来源：
KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY | 2009年 / 19卷
关键词：
TCA; SSRI; SNRI; NRI; MAOI;
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Considering the pathophysiology of depression, we may talk about the alteration of several receptors, enzymes, neurotransmitters or secondary messengers. Current antidepressants are thought to act by restoring these alterations. Despite having different mechanism of actions, antidepressants act on these interconnected systems to increase CREB or BDNF, thus they have a similar effect on the final biological pathway. However, since antidepressants act on different receptors, the time to response and the symptom profile they act on at the beginning of the therapy may differ. Thus it would be rational to consider the symptom profile and desired time to response when choosing among antidepressants with different mechanism of action or switching from one antidepressant to another.
引用
收藏
页码：S86 / S89
页数：4
相关论文
共 50 条
  • [21] ROLE OF THE MESOLIMBIC DOPAMINE SYSTEM IN THE MECHANISM OF ACTION OF ANTIDEPRESSANTS
    SERRA, G
    COLLU, M
    DAQUILA, PS
    GESSA, GL
    [J]. PHARMACOLOGY & TOXICOLOGY, 1992, 71 : 72 - 85
  • [22] Plasma BDNF as a peripheral marker for the action mechanism of antidepressants
    Kim, Y. K.
    Lee, H. Y.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2007, 17 : S312 - S313
  • [23] MECHANISM OF ACTION OF TRICYCLIC ANTIDEPRESSANTS - BIOCHEMICAL AND ELECTROPHYSIOLOGICAL STUDIES
    SCHULTZ, J
    SCHOCKER, W
    SIGGINS, GR
    [J]. HOPPE-SEYLERS ZEITSCHRIFT FUR PHYSIOLOGISCHE CHEMIE, 1978, 359 (04): : 462 - 463
  • [24] Action learning and action research - revisiting similarities, differences, complementarities and whether it matters
    Rigg, Clare
    Coghlan, David
    [J]. ACTION LEARNING, 2016, 13 (03): : 201 - 203
  • [25] Comparison of UCN-01 and a novel cell cycle checkpoint inhibitor: similarities and differences in their mechanism of action.
    Kohn, EA
    Blank, DH
    Gribble, GW
    Eastman, A
    [J]. CLINICAL CANCER RESEARCH, 2001, 7 (11) : 3792S - 3792S
  • [26] Similarities and differences for membranotropic action of three unnatural antimicrobial peptides
    Oliva, Rosario
    Chino, Marco
    Lombardi, Angelina
    Nastri, Flavia
    Notomista, Eugenio
    Petraccone, Luigi
    Del Vecchio, Pompea
    [J]. JOURNAL OF PEPTIDE SCIENCE, 2020, 26 (08)
  • [27] Anxiogenic component in the mechanism of action of antidepressants is essential for clinical effect
    Allikmets, L
    Matto, V
    Harro, J
    [J]. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1996, 354 (04) : 143 - 143
  • [28] Epiphenomenal, causal, or correlational - More on the mechanism(s) of action of antidepressants
    Shader, RI
    Fogelman, SM
    Greenblatt, DJ
    [J]. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 1998, 18 (04) : 265 - 267
  • [29] Necessity for placebo-controlled studies on the action mechanism of antidepressants
    Möller, HJ
    [J]. PSYCHOPHARMAKOTHERAPIE, 2003, 10 (03): : 85 - 86
  • [30] Brain-mapping in depressions: Antidepressants with the different mechanism of action
    Grigorieva, E
    Dyakonov, A
    [J]. EUROPEAN PSYCHIATRY, 2005, 20 : S132 - S132
12345